Updates of Overactive Bladder (OAB) Management Review

Maged Naser, Mohamed M. Nasr, Lamia H. Shehata

Abstract


Overactive bladder disorder (OAB) is characterized as urinary urgency, usually joined by frequent infection   or with evident pathology. In this review, we center on late advances in the management of OAB. We look at the proof on the impact of anticholinergic load on OAB patients. Advances in clinical treatment incorporate another beta-3 agonist, vibegron, which is thought to have fewer drug interactions than mirabegron. Treatment of genitourinary condition of the menopause with estrogens and ospemifene have additionally indicated guarantee for OAB. Botulinum toxin has been demonstrated to be a powerful treatment choice. We talk about the new implantable neuromodulators that are available just as specific bladder enervation and laser innovation, Surgeries are bound to be executed to cure UI however are related with more adverse events . In the most recent decade, laser treatment of SUI and of the genitourinary disorder of menopause (GSM) has been indicated a promising treatment technique.


Keywords


(Overactive bladder, Urinary incontinence, Bladder botulinum toxin (Botox) injection, Anticholinergics, Percutaneous tibial nerve stimulation , Sacral neuromodulation, laser treatment)

Full Text:

PDF

References


- Stewart, W. (2001). The prevalence and impact of overactive bladder in the US: results from the NOBLE program. Neurourol Urodynam., 20, 406-408.‏

- Onukwugha, E., Zuckerman, I. H., McNally, D., Coyne, K. S., Vats, V., & Mullins, C. D. (2009). The total economic burden of overactive bladder in the United States: a disease-specific approach. Am J Manag Care, 15(4 Suppl), S90-7.‏

- Hu TW, Wagner TH, Bentkover JD, Leblanc K, Zhou SZ, Hunt T. Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology. 2004 Mar; 63(3):461-5. Doi: 10.1016/j.urology.2003.10.037. PMID: 15028438.

- Messelink, B., Benson, T., Berghmans, B., Bo, K., Corcos, J., Fowler, C., & Pemberton, J. (2005). Standardization of terminology of pelvic floor muscle function and dysfunction: report from the pelvic floor clinical assessment group of the International Continence Society. Neurourology and Urodynamics: Official Journal of the International Continence Society, 24(4), 374-380.‏

- Pratt, T. S., & Suskind, A. M. (2018). Management of overactive bladder in older women. Current urology reports, 19(11), 92.‏

- Dumoulin, C., Hay‐Smith, J., Habée‐Séguin, G. M., & Mercier, J. (2015). Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women: a short version Cochrane systematic review with meta‐analysis. Neurourology and urodynamics, 34(4), 300-308.‏

- White, N., & Iglesia, C. B. (2016). Overactive bladder. Obstetrics and Gynecology Clinics, 43(1), 59-68.‏

- Shamliyan, T., Wyman, J., & Kane, R. L. (2012). Nonsurgical treatments for urinary incontinence in adult women: diagnosis and comparative effectiveness.‏

- Madhuvrata, P., Cody, J. D., Ellis, G., Herbison, G. P., & Hay‐Smith, E. J. C. (2012). Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database of Systematic Reviews, (1).‏

- Nabi, G., Cody, J. D., Ellis, G., Hay‐Smith, J., & Herbison, G. P. (2006). Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane database of systematic reviews, (4).‏

- Kleeman, S. D., & Karram, M. M. (2007). Overactive bladder syndrome and nocturia. In Urogynecology and reconstructive pelvic surgery (pp. 353-376). Mosby.‏

- Fantl, J. A., Wyman, J. F., McClish, D. K., Harkins, S. W., Elswick, R. K., Taylor, J. R., & Hadley, E. C. (1991). Efficacy of bladder training in older women with urinary incontinence. Jama, 265(5), 609-613.‏

- Jarvis, G. J., & Millar, D. R. (1980). Controlled trial of bladder drill for detrusor instability. British Medical Journal, 281(6251), 1322.‏

- Kelleher, C. J., Cardozo, L. D., Khullar, V., & Salvatore, S. (1997). A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. BJOG: An International Journal of Obstetrics & Gynaecology, 104(9), 988-993.‏

- Nitti, V. W., Dmochowski, R., Herschorn, S., Sand, P., Thompson, C., Nardo, C., & EMBARK Study Group. (2013). OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. The Journal of urology, 189(6), 2186-2193.‏

- Duthie, J. B., Vincent, M., Herbison, G. P., Wilson, D. I., & Wilson, D. (2011). Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database of Systematic Reviews, (12).‏

- Visco, A. G., Brubaker, L., Richter, H. E., Nygaard, I., Paraiso, M. F. R., Menefee, S. A., ... & Spino, C. (2012). Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. New England Journal of Medicine, 367(19), 1803-1813.‏

- Yokoyama, T., Chancellor, M. B., Oguma, K., Yamamoto, Y., Suzuki, T., Kumon, H., & Nagai, A. (2012). Botulinum toxin type A for the treatment of lower urinary tract disorders. International Journal of Urology, 19(3), 202-215.‏

Popat, R., Apostolidis, A., Kalsi, V., Gonzales, G., Fowler, C. J., & Dasgupta, P. (2005). A comparison between the response of patients with idiopathic detrusor over activity and neurogenic detrusor over activity to the first intradetrusor injection of botulinum-A toxin. The Journal of urology, 174(3), 984-989.

-Schmid DM, Sauermann P, Werger M, et al. Experience with 100 cases treatedwith botulinum-A toxin injections in the detrusor muscle for idiopathic overactivebladdersyndromerefractorytoanticholinergics.JUrol2006; 176:177–85

- Compérat, E., Reitz, A., Delcourt, A., Capron, F., Denys, P., & Chartier-Kastler, E. (2006). Histologic features in the urinary bladder wall affected from neurogenic over activity—a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A. European urology, 50(5), 1058-1064.‏

- Gaziev, G., Topazio, L., Iacovelli, V., Asimakopoulos, A., Di Santo, A., De Nunzio, C., & Finazzi-Agrò, E. (2013). Percutaneous tibial nerve stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review. BMC urology, 13(1), 1-11.‏

- Burton, C., Sajja, A., & Latthe, P. M. (2012). Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: A systematic review and meta‐analysis. Neurourology and urodynamics, 31(8), 1206-1216.‏

- Peters, K. M., Carrico, D. J., Perez-Marrero, R. A., Khan, A. U., Wooldridge, L. S., Davis, G. L., & MacDiarmid, S. A. (2010). Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. The Journal of urology, 183(4), 1438-1443.‏

- Peters, K. M., MacDiarmid, S. A., Wooldridge, L. S., Leong, F. C., Shobeiri, S. A., Rovner, E. S., ... & Feagins, B. A. (2009). Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. The Journal of urology, 182(3), 1055-1061.‏

- Finazzi-Agrò, E., Petta, F., Sciobica, F., Pasqualetti, P., Musco, S., & Bove, P. (2010). Percutaneous tibial nerve stimulation effects on detrusor over activity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial. The Journal of urology, 184(5), 2001-2006.‏

- Peters, K. M., Carrico, D. J., Perez-Marrero, R. A., Khan, A. U., Wooldridge, L. S., Davis, G. L., & MacDiarmid, S. A. (2010). Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. The Journal of urology, 183(4), 1438-1443.‏

- Herbison, G. P., & Arnold, E. P. (2009). Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Cochrane database of systematic reviews, (2).‏

- van Kerrebroeck, P. E., van Voskuilen, A. C., Heesakkers, J. P., Lycklama á Nijholt, A. A., Siegel, S., Jonas, U., ... & Cappellano, F. (2007). Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. The Journal of urology, 178(5), 2029-2034.‏

- Groen, J., Blok, B. F., & Bosch, J. R. (2011). Sacral neuromodulation as treatment for refractory idiopathic urge urinary incontinence: 5-year results of a longitudinal study in 60 women. The Journal of urology, 186(3), 954-959.‏

- Siddiqui, N. Y., Wu, J. M., & Amundsen, C. L. (2010). Efficacy and adverse events of sacral nerve stimulation for overactive bladder: a systematic review. Neurourology and urodynamics, 29(S1), S18-S23.‏

- Fistonić, N., Fistonić, I., Lukanovič, A., Guštek, Š. F., Turina, I. S. B., & Franić, D. (2015). First assessment of short-term efficacy of Er: YAG laser treatment on stress urinary incontinence in women: prospective cohort study. Climacteric, 18(sup1), 37-42.

‏ Klovning, A., Avery, K., Sandvik, H., & Hunskaar, S. (2009). Comparison of two questionnaires for assessing the severity of urinary incontinence: the ICIQ‐UI SF versus the incontinence severity index. Neurourology and Urodynamics: Official Journal of the International Continence Society, 28(5), 411-415.‏

- Ogrinc, U. B., Senčar, S., & Lenasi, H. (2015). Novel minimally invasive laser treatment of urinary incontinence in women. Lasers in surgery and medicine, 47(9), 689-697.‏

- Tien, Y. W., Hsiao, S. M., Lee, C. N., & Lin, H. H. (2017). Effects of laser procedure for female urodynamic stress incontinence on pad weight, urodynamics, and sexual function. International urogynecology journal, 28(3), 469-476.‏

- Gambacciani, M., Levancini, M., Russo, E., Vacca, L., Simoncini, T., & Cervigni, M. (2018). Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric, 21(2), 148-152.‏

- Pardo, J. I., Sola, V. R., & Morales, A. A. (2016). Treatment of female stress urinary incontinence with Erbium-YAG laser in non-ablative mode. European Journal of Obstetrics & Gynecology and Reproductive Biology, 204, 1-4.‏

- Leshunov, E. V., & Martov, A. G. (2015). Application of laser technologies for treatment of urinary stress incontinence in women of reproductive age. Urologiia (Moscow, Russia: 1999), (1), 36-40.‏

- Neimark, A. I., Yakovleva, A. Y., & Lapii, G. A. (2018). Outcomes of ER: YAG LASER treatment of stress urinary incontinence in women. Urologiia (Moscow, Russia: 1999), (2), 20-25.‏

- Blaganje, M., Šćepanović, D., Žgur, L., Verdenik, I., Pajk, F., & Lukanović, A. (2018). Non-ablative Er: YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: a randomized controlled trial. European Journal of Obstetrics & Gynecology and Reproductive Biology, 224, 153-158.‏

- Tadir, Y., Gaspar, A., Lev‐Sagie, A., Alexiades, M., Alinsod, R., Bader, A., & Iglesia, C. B. (2017). Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies. Lasers in surgery and medicine, 49(2), 137-159.‏

- Isaza, P. G., Jaguszewska, K., Cardona, J. L., & Lukaszuk, M. (2018). Long-term effect of thermo ablative fractional CO 2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause. International urogynecology journal, 29(2), 211-215.‏

- Pitsouni, E., Grigoriadis, T., Tsiveleka, A., Zacharakis, D., Salvatore, S., & Athanasiou, S. (2016). Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: an observational study. Maturitas, 94, 131-136.‏

- Golubnitschaja, O., Kinkorova, J., & Costigliola, V. (2014). Predictive, preventive and personalised medicine as the hardcore of ‘Horizon 2020’: EPMA position paper. EPMA Journal, 5(1), 6.‏

- Fistonić, I., & Fistonić, N. (2018). Baseline ICIQ‐UI score, body mass index, age, average birth weight, and perineometry duration as promising predictors of the short‐term efficacy of Er: YAG laser treatment in stress urinary incontinent women: A prospective cohort study. Lasers in surgery and medicine, 50(6), 636-643.‏

- Lane, T. M., & Shah, P. J. R. (2000). Valsalva leak point pressure in the evaluation of stress urinary incontinence. Braz J Urol, 26, 420-425.‏

- McGuire, E. J., Fitzpatrick, C. C., Wan, J., Bloom, D., Sanvordenker, J., Ritchey, M., & Gormley, E. A. (1993). Clinical assessment of urethral sphincter function. The Journal of urology, 150(5 Part 1), 1452-1454.‏

- Patel, F. (2017). The effects of RF excited fractional CO2 laser on the vaginal canal in treating stress urinary incontinence [2G]. Obstetrics & Gynecology, 129(5), 71S-72S.‏




DOI: http://dx.doi.org/10.52155/ijpsat.v23.2.2433

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Maged Naser, Mohamed M. Nasr, Lamia H. Shehata

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.